evid
sustain
transmiss
countri
coronaviru
diseas
declar
global
pandem
data
urgent
need
risk
factor
associ
clinic
outcom
retrospect
chart
review
hospit
patient
wuhan
conduct
patient
classifi
three
diseas
sever
group
nonsever
sever
critic
base
initi
clinic
present
clinic
outcom
design
favor
unfavor
base
diseas
progress
respons
treatment
logist
regress
model
perform
identifi
factor
associ
clinic
outcom
logrank
test
conduct
associ
clinic
progress
current
standard
treatment
show
signific
improv
patient
outcom
studi
univari
logist
regress
model
risk
factor
significantli
associ
clinic
outcom
multivari
regress
indic
age
year
smoke
critic
diseas
statu
diabet
high
hypersensit
troponin
pgml
leukocytosi
x
l
neutrophilia
x
l
predict
unfavor
clinic
outcom
contrast
use
hypnot
significantli
associ
favor
outcom
surviv
analysi
also
confirm
patient
receiv
hypnot
significantli
better
surviv
knowledg
first
indic
hypnot
could
effect
ancillari
treatment
also
found
novel
risk
factor
higher
hypersensit
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
coronaviru
diseas
potenti
lethal
respiratori
ill
caus
newli
identifi
coronaviru
name
sar
coronaviru
first
recogn
decemb
wuhan
hubei
provinc
china
diseas
spread
rapidli
countri
march
confirm
case
death
offici
report
worldwid
sustain
transmiss
six
contin
world
health
organ
recent
declar
global
pandem
previou
studi
focus
primarili
epidemiolog
clinic
characterist
wang
cowork
compar
clinic
featur
hospit
patient
nonsever
sever
guan
colleagu
updat
clinic
characterist
diseas
sever
laboratoryconfirm
case
throughout
china
studi
investig
risk
factor
clinic
outcom
urgent
identifi
potenti
novel
risk
factor
treatment
associ
patientcent
outcom
studi
analyz
clinic
cours
hospit
patient
januari
march
wuhan
identifi
risk
factor
associ
clinic
outcom
improv
manag
guidelin
institut
ethic
board
tianyou
hospit
affili
wuhan
univers
scienc
technolog
approv
conduct
retrospect
review
oral
consent
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
obtain
patient
written
inform
consent
waiv
tianyou
hospit
one
sever
design
hospit
treatment
wuhan
electron
medic
record
emr
inpati
tianyou
hospit
studi
diagnosi
compli
interim
guidanc
total
patient
enrol
januari
februari
realtim
revers
transcript
polymeras
chain
reaction
rrtpcr
perform
throat
swab
specimen
patient
clinic
sign
diseas
onset
laboratori
test
includ
rrtpcr
ct
treatment
comorbid
complic
outcom
data
collect
emr
raw
data
initi
assess
train
physician
base
clinic
present
time
admiss
patient
categor
one
three
group
nonsever
sever
critic
clinic
outcom
favor
unfavor
base
averag
observ
period
day
march
final
followup
date
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
diseas
sever
group
includ
follow
nonsever
patient
show
fever
respiratori
symptom
ct
present
pneumonia
sever
patient
show
respiratori
distress
breathsmin
oxygen
satur
less
arteri
partial
pressur
oxygenoxygen
concentr
less
mmhg
critic
patient
show
respiratori
failur
requir
ventilatori
support
well
shock
organ
dysfunct
requir
intens
care
diseas
improv
favor
clinic
outcom
includ
full
recoveri
discharg
progress
criticalsever
nonsever
diseas
statu
pcr
posit
neg
andor
mainten
nonsever
statu
diseas
progress
unfavor
clinic
outcom
includ
death
progress
nonsever
severecrit
diseas
statu
sever
critic
statu
andor
mainten
sever
critic
statu
chisquar
test
fisher
exact
test
use
categor
variabl
measur
continu
variabl
student
ttest
mannwhitney
test
use
multipl
imput
conduct
handl
miss
data
odd
ratio
or
confid
interv
ci
calcul
use
univari
multivari
logist
regress
model
surviv
analysi
surviv
time
defin
interv
date
admiss
date
death
discharg
associ
risk
factor
clinic
outcom
analyz
use
kaplanmei
method
logrank
test
analys
implement
r
softwar
version
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doiorg
statist
analysi
system
sa
softwar
version
sa
institut
inc
cari
nc
p
valu
twosid
consid
statist
signific
patient
rrtpcr
posit
patient
rrtpcr
neg
typic
chest
ct
imag
respiratori
symptom
compat
blood
test
result
time
admiss
end
studi
patient
recov
discharg
patient
die
overal
case
fatal
rate
patient
still
hospit
base
initi
clinic
present
patient
classifi
nonsever
sever
critic
diseas
group
tabl
gender
differ
three
group
median
age
patient
year
rang
patient
year
overrepres
within
sever
critic
diseas
group
admiss
fever
cough
common
symptom
dyspnea
chest
distress
headach
uncommon
averag
observ
period
patient
day
rang
day
favor
outcom
record
patient
unfavor
outcom
patient
among
three
diseas
sever
group
patient
non
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
sever
sever
group
respect
favor
outcom
contrast
patient
critic
group
unfavor
outcom
figur
patient
older
year
show
unfavor
favor
outcom
patient
diabet
bodi
mass
index
bmi
like
unfavor
outcom
tabl
zopiclon
cyclopyrroloneclass
drug
insomnia
administ
dose
mg
per
day
patient
durat
hospit
overal
favor
outcom
record
patient
tabl
compar
hypnot
nonhypnot
use
patient
within
three
diseas
group
favor
clinic
outcom
preval
among
patient
hypnot
vs
nonsever
vs
sever
vs
critic
p
figur
favor
clinic
outcom
associ
administr
hypnot
among
rrtpcrposit
rrtpcrneg
patient
diseas
sever
group
figur
radiolog
laboratori
test
result
summar
tabl
complet
version
avail
supplementari
tabl
ct
abnorm
found
patient
groundglass
opac
ggo
find
bilater
patient
nonsever
sever
critic
diseas
group
respect
multipl
bilater
pulmonari
consolid
intralocular
interstiti
thicken
observ
frequent
among
patient
unfavor
outcom
favor
outcom
repres
ct
imag
relat
clinic
outcom
shown
figur
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
laboratori
find
patient
favor
unfavor
outcom
show
differ
leukocyt
neutrophil
count
creactiv
protein
well
lactat
dehydrogenas
creatinin
alanin
aminotransferas
aspart
aminotransferas
blood
urea
nitrogen
glucos
serum
amyloid
higher
among
patient
unfavor
outcom
lymphopenia
also
occur
among
patient
unfavor
outcom
ddimer
show
signific
differ
time
admiss
initi
rrtpcr
posit
case
neg
rrtpcr
posit
often
among
patient
critic
sever
diseas
group
nonsever
group
patient
whose
rrtpcr
initi
neg
also
better
clinic
outcom
unfavor
outcom
result
relat
treatment
complic
shown
tabl
oseltamivir
ganciclovir
arbidol
three
frequent
use
antivir
medic
one
cours
moxifloxacin
broadspectrum
antibiot
administ
patient
also
patient
given
corticosteroid
glucocorticoid
receiv
altern
therapi
tradit
chines
medicin
lopinavirritonavir
antiretrovir
drug
human
immunodefici
viru
infect
administ
patient
critic
diseas
group
unfavor
favor
outcom
vs
also
given
often
patient
unfavor
favor
outcom
vs
medic
show
signific
differ
clinic
outcom
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
oxygen
therapi
via
invas
ventil
noninvas
ventil
also
given
often
patient
unfavor
clinic
outcom
compar
outcom
treatment
within
nonsever
sever
critic
diseas
group
clear
improv
figur
patient
unfavor
outcom
complic
arrhythmia
vs
acut
lung
injuri
vs
shock
vs
acut
cardiac
injuri
vs
acut
respiratori
distress
syndrom
vs
significantli
common
patient
favor
outcom
tabl
total
categor
variabl
identifi
univari
logist
regress
analysi
name
age
smoke
bmi
hypnot
dyspnea
diabet
malign
cardiovascular
cerebrovascular
diseas
serum
amyloid
procalcitonin
hypersensit
troponin
creatin
kinas
cmb
lactat
dehydrogenas
alanin
aminotransferas
aspart
aminotransferas
blood
urea
nitrogen
creatinin
glucos
leukocyt
count
neutrophil
count
platelet
count
rrtpcr
diagnosi
clinic
statu
admiss
bilater
ggo
crazi
pave
sign
diffus
patchi
ground
glass
air
bronchogram
multipl
bilater
pulmonari
consolid
intralobular
interstiti
thicken
tabl
eight
variabl
demonstr
independ
risk
factor
base
multivari
logist
regress
model
result
indic
age
patient
year
smoke
critic
diseas
design
diabet
abnorm
higher
hypersensit
troponin
pgml
leukocyt
count
l
neutrophil
count
l
significantli
associ
unfavor
clinic
outcom
hypnot
show
signific
benefici
effect
clinic
outcom
p
figur
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
patient
nonsever
group
show
significantli
better
surviv
compar
sever
critic
group
figur
patient
given
hypnot
show
signific
favor
surviv
compar
nonhypnot
figur
patient
posit
rrtpcr
result
show
significantli
poorer
surviv
compar
neg
rrtpcr
figur
contrast
previou
studi
patient
sever
group
seri
show
favor
clinic
outcom
approxim
frequenc
nonsever
case
vs
surviv
analysi
demonstr
consist
higher
surviv
rate
nonsever
sever
case
critic
case
although
previou
studi
fail
show
smoke
risk
factor
multivari
analysi
studi
demonstr
smoke
independ
risk
factor
unfavor
outcom
otherwis
confirm
find
studi
age
year
leukocytosi
left
shift
associ
poorer
clinic
outcom
zopiclon
commonli
prescrib
nonbenzodiazepin
soporif
significantli
associ
improv
clinic
outcom
patient
take
hypnot
show
better
outcom
diseas
stage
take
hypnot
patient
sever
diseas
group
improv
effect
even
pronounc
also
analyz
effect
hypnot
rrtpcrposit
rrtpcrneg
patient
separ
found
hypnot
strike
effect
former
moreov
hypnot
identifi
independ
factor
risk
model
contribut
better
clinic
outcom
also
patient
administ
hypnot
better
surviv
rate
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
patient
usual
show
strong
anxieti
sleep
defici
oxygen
insuffici
diseas
progress
lead
metabol
dysregul
immun
system
abnorm
better
sleep
qualiti
stress
reduct
could
one
partial
reason
prescrib
hypnot
patient
dimitrov
et
al
indic
sleep
exert
immunesupport
effect
potenti
enhanc
effect
cell
respons
high
relev
specif
sleep
disord
impair
sleep
depress
chronic
stress
addit
superior
efficaci
zopiclon
may
due
enhanc
gamma
aminobutyr
acid
gaba
signal
zopiclon
interact
gabaa
gabaa
receptor
magnifi
respons
gaba
gaba
signal
promot
autophagi
activ
improv
phagosom
matur
promot
host
protect
infect
knowledg
benefici
effect
hypnot
clinic
outcom
report
previous
manag
patient
till
sever
descript
studi
mention
noneffect
function
current
medic
treatment
matter
stage
outcom
accord
studi
analysi
specif
compar
standard
treatment
effect
diseas
statu
treatment
figur
nt
see
standard
therapi
could
improv
clinic
outcom
studi
howev
sinc
patient
studi
took
hypnot
assum
selfheal
could
major
reason
high
recoveri
rate
patient
nonsever
sever
diseas
group
like
selflimit
diseas
major
patient
rrtpcrconfirm
patient
clinic
diagnos
patient
rrtpcr
neg
includ
studi
due
burgeon
epidem
high
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
sinc
patient
studi
test
experienc
team
use
rrtpcr
protocol
believ
major
reason
neg
rrtpcr
result
patient
seri
due
low
concentr
viru
throat
may
indic
patient
neg
rrtpcr
test
might
less
like
infect
peopl
found
small
portion
patient
less
neg
rrtpcr
unfavor
outcom
perform
followup
rrtpcr
patient
sever
diseas
group
abnorm
ct
found
case
whose
first
test
neg
later
test
posit
believ
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
inclus
rrtpcrneg
patient
clinic
compat
present
help
guid
clinician
care
patient
higher
bmi
hyperglycemia
diabet
cardiovascular
diseas
distinct
risk
factor
unfavor
clinic
outcom
angiotensinconvert
serv
cellentri
receptor
sar
play
protect
role
diabet
cardiovascular
diseas
kuba
colleagu
demonstr
sar
cov
downregul
protein
could
explain
patient
diabet
cardiovascular
diseas
wors
clinic
outcom
found
abnorm
high
hypersensit
troponin
independ
predictor
poor
clinic
outcom
increas
troponin
enhanc
coagul
activ
patient
immun
damag
hematopoiet
system
ischem
hypoxiareperfus
injuri
drug
caus
coagul
disord
specul
increas
troponin
induc
dysfunct
coagul
thrombu
format
possibl
pulmonari
embol
would
aggrav
patient
condit
limit
studi
incomplet
laboratori
test
result
patient
record
may
caus
deviat
statist
analysi
except
hypnot
found
treatment
ineffect
mani
treatment
show
unwant
side
effect
includ
liver
injuri
although
conduct
separ
analysi
rrtpcrposit
rrtpcrneg
patient
multivari
analysi
identifi
eight
independ
risk
factor
independ
rrtpcr
result
although
vast
major
patient
recov
approxim
hospit
patient
cohort
unfavor
clinic
outcom
extent
chronic
respiratori
insuffici
organ
system
sequela
occur
patient
requir
care
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
prolong
followup
studi
far
seem
effect
standard
treatment
howev
found
use
hypnot
could
significantli
improv
clinic
outcom
also
found
novel
risk
factor
could
predict
patient
outcom
help
earli
decis
make
improv
treatment
outcom
patient
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
yearold
male
patient
progress
nonsever
critic
diseas
group
die
day
day
day
pleura
scatter
shadow
frost
glass
larg
sheet
diffus
pave
stone
lung
extens
consolid
lung
thicken
interlobular
stroma
repetit
ct
imag
femal
patient
progress
critic
nonsever
diseas
group
day
exhibit
extens
consolid
lung
day
exhibit
frost
hyalin
chang
pave
stone
sign
day
show
signific
resolut
groundglass
opac
subpleur
cord
chang
associ
clinic
outcom
three
diagnosi
statu
nonsever
sever
critic
treatment
kaletra
b
interferon
c
invas
ventil
noninvas
ventil
percentag
calcul
number
outcom
group
unfavor
favor
divid
total
number
diagnosi
statu
ye
use
use
treatment
ye
nonsever
sever
nonsever
sever
nonsever
sever
nonsever
sever
critic
c
b
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
